Paper29948899
N-terminal domain of the RNA polymerase of very virulent infectious bursal disease virus contributes to viral replication and virulence.
Gao L and 6 others. Sci China Life Sci, 2018. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. N-terminal domain of the RNA polymerase of very virulent infectious bursal disease virus contributes to viral replication and virulence. Papers, record 29948899. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29948899
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- N-terminal domain of the RNA polymerase of very virulent infectious bursal disease virus contributes to viral replication and virulence.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA-Directed RNA Polymerases | Major topic |
| Infectious bursal disease virus | Major topic |
| Viral Structural Proteins | Major topic |
| Virus Replication | Major topic |
| Animals | |
| Binding Sites | |
| Birnaviridae Infections | |
| Chickens | |
| Poultry Diseases | |
| Virulence |
Source PubMed
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41472004 | Advances in Infectious Bursal Disease Virus Vaccines-A Review. | Microorganisms | 2025 | https://conductscience.org/library/papers/41472004 | PubMed |
| 39268520 | The complete protections induced by the oil emulsion vaccines of the novel variant infectious bursal disease viruses against the homologous challenges indicating the important roles of both VP2 and VP1 in the antigenicity and pathogenicity of the virus. | Front Vet Sci | 2024 | https://conductscience.org/library/papers/39268520 | PubMed |
| 38075867 | Genetic and pathogenic characterizations of a naturally occurring reassortant and homologous recombinant strain of the classical infectious bursal disease virus re-emerging in chickens in southern China. | Front Microbiol | 2023 | https://conductscience.org/library/papers/38075867 | PubMed |
| 37175960 | Genetic Insight into the Interaction of IBDV with Host-A Clue to the Development of Novel IBDV Vaccines. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37175960 | PubMed |
| 33466596 | The Full Region of N-Terminal in Polymerase of IBDV Plays an Important Role in Viral Replication and Pathogenicity: Either Partial Region or Single Amino Acid V4I Substitution Does Not Completely Lead to the Virus Attenuation to Three-Yellow Chickens. | Viruses | 2021 | https://conductscience.org/library/papers/33466596 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29948899
GET https://conductscience.org/api/papers/v1/29948899/authors